selected publications
-
journal article
-
TFIIH kinase CDK7 drives cell proliferation through a common core transcription factor network..
Science Advances.
eadr9660.
2025
-
A Highly Anticipated Selective Therapeutic Agent against CDK2: INX-315.
Cancer Discovery.
386-388.
2024
-
Rapid adaptation to CDK2 inhibition exposes intrinsic cell-cycle plasticity.
Cell.
2628-+.
2023
-
Replication timing maintains the global epigenetic state in human cells.
Science.
371-+.
2021
-
The RIF1-long splice variant promotes G1 phase 53BP1 nuclear bodies to protect against replication stress.
eLife.
2020
-
TFIIH kinase CDK7 drives cell proliferation through a common core transcription factor network..
Science Advances.
eadr9660.
2025